Barely Significant
← all excerpts

Prophylactic ulinastatin administration for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: A meta-analysis.

Exp Ther Med · 2017 · PMC5613208 · PMID 28966682

Europe PMCDOI
1
hedged sentence
0.0020
closest p · 0.0× alpha
0.0020
boldest claim

The sentences

marginally significantP=0.002actually significant
Using a fixed-effects model, the marginally significant reduction of the risk of post-ERCP abdominal pain associated with ulinastatin reached statistical significance (RR=0.71; 95% CI: 0.57–0.88; P=0.002; I 2 =67).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.